Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
09/2005
09/15/2005WO2005085210A1 Nitriles and medicinal compositions containing the same as the active ingredient
09/15/2005WO2005085201A1 Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein
09/15/2005WO2005085200A1 Pyridone derivative
09/15/2005WO2005085195A1 Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder
09/15/2005WO2005084701A1 Combination of morphogenic proteins having tissue inductive properties
09/15/2005WO2005084689A1 Radix astragli extract and production method and use thereof
09/15/2005WO2005084684A1 Use of a mixture for the production of an agent for treating defective or degenerated cartilage in the production of natural cartilage replacement in vitro
09/15/2005WO2005084679A1 Composition containing benzamidine derivative and method for stabilizing benzamidine derivative
09/15/2005WO2005084664A1 Indole derivatives and uses thereof
09/15/2005WO2005065050A3 Bicyclic compound
09/15/2005WO2005025504A3 Modulators of calcitonin and amylin activity
09/15/2005WO2004100924A3 Method of preparing a formulation containing a microdosed active principle
09/15/2005US20050203145 Chronic inflammation, rheumatoid arthritis, colitis, asthma and psoriasis; solid phase synthetic methods to efficiently construct numerous drug-like libraries
09/15/2005US20050203126 Inhibitors of basic fibroblast growth factors (FGFs); treating cancer, rheumatoid arthritis, inflammatory bowel disease, cardiovascular disorders, diabetic retinopathy, achondroplasia, hypochondoplasia, or thanathophoric dysplasia
09/15/2005US20050203114 Pyrimidine-indole derivatives; cancer, autoimmunological, metabolic, inflammatory, infection (bacterial, viral, yeast, fungal, etc.), diseases of the central nervous system, degenerative neural disease, allergy/asthma, dermatology, angiogenesis, neovascularization, vasculogenesis, and cardiovascular
09/15/2005US20050203109 Novel Compounds
09/15/2005US20050203107 Reversible inhibitors of cysteine proteases S, K, F, L and B; inhibiting Cathepsin S; analgesics; 1-[9-(4-Chlorophenyl)-2-cyano-9H-purin-6-yl]-L-prolinamide for example
09/15/2005US20050203084 Protease inhibitors
09/15/2005US20050203071 Use of carbon-2-modified-19-nor-vitamin d analogs to induce the formation of new bone
09/15/2005US20050203012 Human parathyroid hormone modifications, preparation and use
09/15/2005US20050202008 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs
09/15/2005CA2559188A1 Hyaluronic acid-methotrexate conjugate
09/15/2005CA2558497A1 Use of a mixture for the production of an agent for treating defective or degenerated cartilage in the production of natural cartilage replacement in vitro
09/15/2005CA2558109A1 Heteroaryl-fused pyrazolo derivatives
09/15/2005CA2557766A1 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
09/15/2005CA2557758A1 Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder
09/15/2005CA2557320A1 Fused heterocyclic derivatives for prevention or treatment of hyperglycemia
09/15/2005CA2555712A1 Novel cyclic compound having 4-pyridylalkylthio group having substituted or unsubstituted amino group introduced therein
09/15/2005CA2555616A1 New therapeutic use for a group of sulphated polysaccharides
09/14/2005EP1574578A1 Monomeric protein of the TGF-beta family
09/14/2005EP1574518A2 Venom-derived vascular endothelial growth factor-like protein having binding activity specific to vascular endothelial growth factor receptor type 2 and use thereof
09/14/2005EP1574212A1 Prevention and treatment of androgen-deprivation induced hot flashes, decreased lean muscle mass, loss of libido or erectile dysfunction
09/14/2005EP1573028A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
09/14/2005EP1573025A2 Crystallized structure of type iv collagen nc1 domain hexamer
09/14/2005EP1572995A2 Novel proteins and nucleic acids encoding same
09/14/2005EP1572934A2 Follistatin domain containing proteins
09/14/2005EP1572930A2 Albumin-fused kunitz domain peptides
09/14/2005EP1572909A2 A follistatin domain containing protein
09/14/2005EP1572891A2 Bone anti-resorptive compounds
09/14/2005EP1572881A2 Tacis and br3 polypeptides and uses thereof
09/14/2005EP1572877A2 Drug metabolizing enzymes
09/14/2005EP1572867A2 Endothelial cell expression patterns
09/14/2005EP1572864A2 Human serpin polypeptides
09/14/2005EP1572863A2 Method for identifying inhibitors of g protein coupled receptor signaling
09/14/2005EP1572684A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5
09/14/2005EP1572683A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5
09/14/2005EP1572667A1 Cathepsin cysteine protease inhibitors and their use
09/14/2005EP1572655A2 Novel arylheteroalkylamine derivatives
09/14/2005EP1572650A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5
09/14/2005EP1572179A1 Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor
09/14/2005EP1572113A2 Calcium receptor modulating compound and use thereof
09/14/2005EP1572078A2 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS
09/14/2005EP1572071A2 Systems and methods for treating patients with processed lipoaspirate cells
09/14/2005EP1572068A2 Arylheteroalkalylamine derivatives and their use as inhibitors of nitric oxide synthase
09/14/2005EP1572065A2 Method and pharmaceutical composition for the treatment of multiple sclerosis
09/14/2005EP1404682B1 Method of inhibiting ptp 1b and/or t-cell ptp and/or other ptpases with an asp residue at position 48
09/14/2005EP1390062A4 Modulators of elastase inhibitor secretion
09/14/2005EP1284958B1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoidane derivatives
09/14/2005EP1283825B1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
09/14/2005EP1274446B1 Polysaccharidic esters of n-derivatives of glutamic acid
09/14/2005EP1250317B1 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments
09/14/2005EP1210335B1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments
09/14/2005EP0981343B1 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
09/14/2005CN1668758A Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
09/14/2005CN1668755A Galactosyl isomalt, method for production and use thereof
09/14/2005CN1668734A Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure
09/14/2005CN1668644A Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer
09/14/2005CN1668628A Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
09/14/2005CN1668622A 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
09/14/2005CN1668619A Imidazo[1, 2-a]pyrazin-8-ylamines, method of making and method of use thereof
09/14/2005CN1668614A Bicyclic piperidine derivatives as antagonists of the CCR1 chemokine receptor
09/14/2005CN1668609A Substituted 4-aryl-4H-pyrrolo[2, 3-H]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
09/14/2005CN1668603A Pyridazin-3(2h)-one derivatives as PDE4 inhibitors
09/14/2005CN1668589A Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments
09/14/2005CN1668588A Indole derivatives, method for preparing same and pharmaceutical compositions containing same
09/14/2005CN1668579A Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands
09/14/2005CN1668336A Drug transport and delivery system
09/14/2005CN1668332A Liquid formulations with a high concentration of human growth hormone (HGH) comprising glycine
09/14/2005CN1668326A Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
09/14/2005CN1668325A Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
09/14/2005CN1668310A Hormone replacement therapy using a combination of conjugated estrogens and trimegestone
09/14/2005CN1668309A Trimegestone and estrogens for treating post menopausal disorders
09/14/2005CN1668299A Methods for using JNK inhibitors for treating or preventing disease-related wasting
09/14/2005CN1668296A Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
09/14/2005CN1668285A Lasofoxifene tablet and its coating
09/14/2005CN1666985A Medical use of andrographolidume and its derivatives and analogs
09/14/2005CN1666775A Pharmaceutical composition for treating hyperosteogeny and intervertebral disc protrusion
09/14/2005CN1666764A Fracture union-promoting medicine and its preparation
09/14/2005CN1666745A Drug composition for treating osteoporosis
09/14/2005CN1219056C Phytase APPB and DNA for coding same
09/14/2005CN1218961C Osteoclast formation inhibitive factor, its nucleotide sequence and preparation method
09/14/2005CN1218943C 4-pyrimidine-N-acyl-L-phenylalanines compound
09/14/2005CN1218940C Nitric oxide synthase inhibitors
09/14/2005CN1218936C Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/14/2005CN1218738C Proprietary Chinese internal medicine for promoting blood circulation to stop pain
09/14/2005CN1218737C Prepared Chinese internal medicine for treating prolapse of intervertebral disc
09/14/2005CN1218735C Medicine composition for treating pain in waist and lower limbs and hyperosteogeny
09/14/2005CN1218729C Xuerongguyugao ointment for healing fracture and its prepn.
09/14/2005CN1218724C Tincture for treating traumatic injury
09/14/2005CN1218722C Lotion for treating hyperosteogeny
1 ... 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 ... 820